1.
Open Forum Infect Dis
; 9(9): ofac440, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36172057
RESUMO
Patients with multidrug-resistant tuberculosis who received regimens containing high-dose isoniazid (INHHD) had similar time to culture conversion and treatment outcomes as patients who received regimens with bedaquiline. INHHD is an inexpensive and safe medication that may contribute additive efficacy in combination regimens.
